Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer (2010)
Source: Urologic Oncology. Unidade: FM
Subjects: NEOPLASIAS DOS GENITAIS MASCULINOS, POLIMORFISMO, PROGNÓSTICO
ABNT
REIS, Sabrina Thalita dos et al. Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer. Urologic Oncology, v. 28, n. 6, p. 624-627, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.urolonc.2008.10.012. Acesso em: 20 out. 2024.APA
Reis, S. T. dos, Villanova, F. E., Andrade, P. M., Pontes Jr., J., Sousa-Canavez, J. M. de, Sañudo, A., et al. (2010). Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer. Urologic Oncology, 28( 6), 624-627. doi:10.1016/j.urolonc.2008.10.012NLM
Reis ST dos, Villanova FE, Andrade PM, Pontes Jr. J, Sousa-Canavez JM de, Sañudo A, Antunes AA, Dall'Oglio MF, Srougi M, Leite KRM. Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer [Internet]. Urologic Oncology. 2010 ; 28( 6): 624-627.[citado 2024 out. 20 ] Available from: https://doi.org/10.1016/j.urolonc.2008.10.012Vancouver
Reis ST dos, Villanova FE, Andrade PM, Pontes Jr. J, Sousa-Canavez JM de, Sañudo A, Antunes AA, Dall'Oglio MF, Srougi M, Leite KRM. Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer [Internet]. Urologic Oncology. 2010 ; 28( 6): 624-627.[citado 2024 out. 20 ] Available from: https://doi.org/10.1016/j.urolonc.2008.10.012